[Piribedil in the treatment of Parkinson disease (author's transl)].
[Piribedil in the treatment of Parkinson disease (author's transl)].
A plain-language reading has not been prepared for this paper yet.
Original abstract
Seventeen patients with either Parkinson's disease or post-encephalitic parkinsonism were treated with Piribedil, an apomorphine-like drug, in single blind conditions for a period ranging from five weeks to twenty-four months. The analysis of the results shows that Piribedil modifies the extrapiramidal symptomatology being specially effective against the tremor either when used alone or in association with L-Dopa. The side effects noticed during treatment with Piribedil are similar to those of Apomorphine, and are dose-dependent.